4Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease.Gastroenterology, 2002, 123: 1705-1725.
5Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology, 2004, 39: 476-483.
6Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med,2000, 132: 112-117.
7Omagari K, Kadokawa Y, Masuda J, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol, 2002, 17:1098-1105.
8刘瑞杰 牛好敏 等.高血脂症和相关疾病[M].北京:科学技术文献出版社,1999,4.91.
9Daskalopoulou SS, Mikhailidis DP, Elisaf M. Prevention and Treatment of the Metabolic Syndrome. Angiology,2004,55(6):589- 612.
10Smith SCJr, Jackson R,Pearson TA,et al. Principles for National and Regional Guidelines on Cardiovascular Disease Prevention: A Scientific Statement From the World Heart and Stroke Forum. Circulation, 2004, 109(25):3 112-3 121.
